580 related articles for article (PubMed ID: 21967114)
1. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
Kavosh ER; Khan DA
Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
[TBL] [Abstract][Full Text] [Related]
2. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
Zuberbier T
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
J Investig Allergol Clin Immunol; 2013; 23(3):141-4; quiz 2 p preceding 145. PubMed ID: 23967751
[TBL] [Abstract][Full Text] [Related]
5. Review of H1 antihistamines in the treatment of chronic idiopathic urticaria.
Monroe E
Cutis; 2005 Aug; 76(2):118-26. PubMed ID: 16209158
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
7. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines.
Gillman S; Gillard M; Strolin Benedetti M
Allergy Asthma Proc; 2009; 30(4):366-76. PubMed ID: 19335943
[TBL] [Abstract][Full Text] [Related]
8. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
Sharma VK; Gupta V; Pathak M; Ramam M
J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
10. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
Grob JJ; Lachapelle JM
Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of desloratadine for the management of allergic disease.
Berger WE
Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
[TBL] [Abstract][Full Text] [Related]
13. Second-Generation H1-Antihistamines for Chronic Spontaneous Urticaria.
Saguil A; Mercado M
Am Fam Physician; 2016 Sep; 94(5):352-3. PubMed ID: 27583420
[No Abstract] [Full Text] [Related]
14. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine.
Kapp A; Wedi B
J Drugs Dermatol; 2004; 3(6):632-9. PubMed ID: 15624746
[TBL] [Abstract][Full Text] [Related]
15. Urticaria and its subtypes: the role of second-generation antihistamines.
Ortonne JP
Eur J Intern Med; 2012 Jan; 23(1):26-30. PubMed ID: 22153526
[TBL] [Abstract][Full Text] [Related]
16. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
[TBL] [Abstract][Full Text] [Related]
17. New oral H1 antihistamines in children: facts and unmeet needs.
de Benedictis FM; de Benedictis D; Canonica GW
Allergy; 2008 Oct; 63(10):1395-404. PubMed ID: 18782118
[TBL] [Abstract][Full Text] [Related]
18. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
19. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
20. Update on prescription and over-the-counter histamine inverse agonists in rhinitis therapy.
DuBuske L; Kowal K
Curr Allergy Asthma Rep; 2009 Mar; 9(2):140-8. PubMed ID: 19210904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
